Intermittent Inotropic Support with Levosimendan in Advanced Heart Failure as Destination Therapy: The LEVO-D Registry

Abstract

In this large real-life series of AHF patients treated with levosimendan as destination therapy, we show a significant decrease of heart failure events during the year after the first administration. The simple LEVO-D Score could be of help when deciding about futile therapy in this population.